NASDAQ · Biotechnology

Immunitybio Inc (IBRX)

$6.02 -8.37%
40 In band Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$7.97-24.47%

Company profile

ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.

SectorHealthcare
IndustryBiotechnology
Market cap$7.10B
P/E ratioNone
EPS$-1.06
Beta0.174
Dividend yield0.00%
52-week high$12.43
52-week low$1.95

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for IBRX

An email when IBRX closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 12:52 AM EST